Dr Mei Mei Tian is a Senior Scientific Advisor on translational Development of Across Pharmaceuticals. Former Vice-President, Head of External Research at Bioasis Technologies Inc. Dr. Tian has more than 15 years of experience working on Melanotransferrin/xB3-related research in both academia and biotech. With her oncology and neurology background, Dr. Tian has been a significant contributor in the intellectual property, early development and continued expansion of the xB3 blood-brain barrier platform technology.
